Please login to the form below

Inyta

This page shows the latest Inyta news and features for those working in and with pharma, biotech and healthcare.

Institute's draft guidance doesn't recommend drug for advanced kidney cancer

CHMP roundup – new drug recommendations in Europe

There were also CHMP decisions this month on Pradaxa's labelling and recommendations for Pfizer's Inyta and Vertex Pharma's cystic fibrosis treatment Kalydeco.
Pfizer's Inlyta backed by EMA for kidney cancer in EU

Agency recommends drug as second-line therapy in adults with advanced renal cell carcinoma

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Add my company

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...